Continuous renal replacement therapy market

Continuous Renal Replacement Therapy Market Size, Share, Growth Analysis, By Product(Dialysate & Replacement Fluids, Disposables, and CRRT Systems), By Modality(Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, and Slow Continuous Ultrafiltration), By Age group(Adults, Pediatrics & Neonates), By End User(Hospitals, Ambulatory Care, Home Care, and Other End Users), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2403 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 88 | Figures: 76

Continuous Renal Replacement Therapy Market News

  • 2021: Baxter International Inc. launched the PrisMax 2 system, the latest version of their next-generation CRRT platform, designed to meet the demands of Intensive Care Units (ICUs) and simplify organ support transfer.
  • Fresenius Medical Care AG & Co. KGaA announced the acquisition of Xenios AG, a company specializing in extracorporeal lung and heart support technologies, expanding their portfolio of critical care therapies.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Continuous Renal Replacement Therapy Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.40 billion in 2023 to USD 2.61 billion by 2031, growing at a CAGR of 8.1% in the forecast period (2024-2031).

The competitive landscape of the Continuous Renal Replacement Therapy (CRRT) market is characterized by the presence of several key players striving for market dominance. Companies such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Infomed SA, Medical Components, Inc., and Bellco S.r.l. are among the prominent players in the market. These companies focus on product innovations, strategic partnerships, mergers and acquisitions, and geographical expansions to gain a competitive edge. Additionally, the market also witnesses the presence of regional players who cater to specific geographical regions, further intensifying the competition. 'Baxter International Inc. (US) ', 'Fresenius Medical Care AG & Co. KGaA (Germany) ', 'Nikkiso Co., Ltd. (Japan) ', 'B. Braun Melsungen AG (Germany) ', 'Medtronic PLC (Ireland) ', 'Asahi Kasei Corporation (Japan) ', 'Toray Medical Co., Ltd. (Japan) ', 'Nipro Corporation (Japan) ', 'Infomed SA (Switzerland) ', 'Medica SPA (Italy) ', 'Medites Pharma Spol. S.R.O. (Czech Republic) ', 'Medical Components, Inc. (US) ', 'SWS Hemodialysis Care Co., Ltd. (China) ', 'Ningbo Tianyi Medical Devices Co., Ltd. (China) ', 'Anjue Medical Equipment Co., Ltd. (China) ', 'Kimal (UK) ', 'Jiangxi Sanxin Medtech Co., Ltd. (China) ', 'Allmed Medical Products Co., Ltd. (China) ', 'Dialco Medical Inc. (US) ', 'Browndove Healthcare Pvt. Ltd. (India) ', 'Steris PLC (US) ', 'Kuraray Medical PLC (Japan) ', 'Livanova PLC (UK) ', 'Diaverum Deutschland GmbH (Germany) ', 'Sembcorp Industries (Singapore)'

Increasing Prevalence of Acute Kidney Injury (AKI): The rising incidence of AKI, particularly in critically ill patients and those with underlying health conditions. AKI is commonly observed in settings such as intensive care units, where CRRT is often used as a renal replacement therapy. The growing prevalence of AKI contributes to the demand for CRRT devices and consumables.

The Continuous Renal Replacement Therapy (CRRT) market is experiencing several key market trends. Firstly, there is a growing demand for CRRT devices and consumables due to the increasing prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) globally. The rising geriatric population and the high incidence of comorbidities such as diabetes and hypertension contribute to the demand for CRRT. Secondly, technological advancements are driving the market, with the development of advanced CRRT machines that offer improved efficiency, safety, and user-friendly interfaces. Integration of electronic medical record (EMR) connectivity and remote monitoring capabilities are enhancing patient care and treatment outcomes. Lastly, there is a rising focus on home-based CRRT, allowing patients to receive continuous renal replacement therapy in the comfort of their own homes. This trend is driven by the advantages of home-based therapy, including improved patient convenience, reduced hospital visits, and potentially lower healthcare costs. Overall, these market trends indicate a growing demand for CRRT and a shift towards more advanced and patient-centric treatment approaches.

North America dominated the continuous renal replacement therapy (CRRT) market with the highest revenue share of 35.6% in 2021. The region's market growth is driven by the increasing prevalence of the geriatric population and the rising incidence of kidney disorders. Unhealthy lifestyles and dietary habits, such as sedentary lifestyles and poor eating habits, contribute to the growing incidence of lifestyle-related diseases like kidney dysfunction, hypertension, and diabetes. In the United States, for example, millions of adults are estimated to have chronic kidney disease (CKD), creating a significant demand for CRRT. These factors contribute to the growth of the CRRT market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Continuous renal replacement therapy market

Report ID: SQMIG35A2403

$5,300
BUY NOW GET FREE SAMPLE